Streetbeat News

Stock Prices

ACET

Adicet Bio (NASDAQ:ACET) reported its Q4 earnings on March 19, 2024, with an EPS of $-0.69, matching the estimated earnings. Revenue remained unchanged from the previous year. In the last quarter, the company exceeded EPS estimates by $0.03, which was followed by a 6.0% decrease in share price the next day.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 9:30 pm

DMAC

DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q4 earnings on March 19, 2024, with an EPS of $-0.14, matching the estimated earnings. The revenue remained unchanged from the same period last year. In the previous quarter, DMAC beat EPS estimates by $0.01, leading to a 7% increase in share price the following day.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 9:25 pm

AMSYF

AUMN

MTAL

NEXA

VALE

Nexa Resources suspends operations at Morro Agudo, impacting zinc and lead production. Metals Acquisition reports high copper grades at CSA Copper Mine, aiming for resource expansion. Golden Minerals announces 2023 financial results, with decreased revenue and a net loss, alongside mining operation updates. ArcelorMittal appoints Kleber Silva as EVP and CEO of its mining division, leveraging his extensive industry experience.

Portfolio Pulse from Austin DeNoce

March 19, 2024 | 9:08 pm

TSHA

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) reported its FY23 results, showing a significant reduction in losses per share from $3.78 to 96 cents and an increase in cash reserves to $143.9 million. The company highlighted progress in its REVEAL Phase 1/2 trial, including expansion into the U.S. and promising safety and efficacy data. Shares surged 31.11% after-hours to $2.95.

Portfolio Pulse from Erica Kollmann

March 19, 2024 | 9:07 pm

CTSH

Nine financial analysts have recently updated their ratings on Cognizant Tech Solns (NASDAQ:CTSH), showing a mix of bullish to bearish sentiments. The average 12-month price target for CTSH has been raised to $81.22, indicating a 6.41% increase from the previous target. Analyst actions include both upgrades and downgrades, with price targets ranging from $67.00 to $90.00. Cognizant's financial performance shows a slight revenue decline but strong profitability metrics, suggesting a mixed financial outlook.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 9:00 pm

TYRA

Tyra Biosciences Inc has filed with the SEC for the resale of up to 15.4 million shares by the selling securityholders. This move could potentially impact the stock's liquidity and market perception.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 9:00 pm

JPM

JPMorgan Chase & Co. (NYSE:JPM) has announced an increase in its quarterly common stock dividend from $1.05 to $1.15 per share, payable on April 30, 2024, to stockholders of record as of April 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:59 pm

DIS

Disney's ESPN and the College Football Playoff have reached a $7.8 billion agreement, ensuring ESPN remains the exclusive rightsholder through the 2031-32 season. The deal includes an expansion to a 12-team format and a new six-year deal starting in the 2026-2027 season for $1.3 billion annually. This agreement enhances ESPN's position as the home of college football and provides expanded sales and sponsorship opportunities for Disney Advertising.

Portfolio Pulse from Adam Eckert

March 19, 2024 | 8:58 pm

MNTS

Momentus shares experienced a downturn after initially spiking due to the company being granted a US patent. The initial excitement over the patent grant led to a temporary increase in stock price, which later reversed.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:52 pm

NDAQ

Nasdaq shares are trading lower following the announcement of a secondary offering of approximately 27 million shares by Borse Dubai Limited.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:51 pm